SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Achouri-Rassas, N. Ben Ali, S. Fray, M. Kechaou, N. Oudiaa Zakraoui, S. Hadj-Fredj, A. Cherif, N. Anane, S. Echebi, T. Messaoud, S. Belal, Association study of apolipoprotein E promoter polymorphism (−427 T/C) and Alzheimer's disease in a Tunisian population, Revue Neurologique, 2016, 172, 2, 127

    CrossRef

  2. 2
    Clive Ballard, William Mobley, John Hardy, Gareth Williams, Anne Corbett, Dementia in Down's syndrome, The Lancet Neurology, 2016, 15, 6, 622

    CrossRef

  3. 3
    Silvia Maioli, Maria Lodeiro, Paula Merino-Serrais, Farshad Falahati, Wasim Khan, Elena Puerta, Alina Codita, Roberto Rimondini, Maria J. Ramirez, Andrew Simmons, Francisco Gil-Bea, Eric Westman, Angel Cedazo-Minguez, Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease, Aging Cell, 2015, 14, 1
  4. 4
    Takashi Amemori, Pavla Jendelova, Jiri Ruzicka, Lucia Urdzikova, Eva Sykova, Alzheimer’s Disease: Mechanism and Approach to Cell Therapy, International Journal of Molecular Sciences, 2015, 16, 11, 26417

    CrossRef

  5. 5
    Vishal Jindal, Interconnection Between Brain and Retinal Neurodegenerations, Molecular Neurobiology, 2015, 51, 3, 885

    CrossRef

  6. 6
    Maria Anna Zipeto, Qingfei Jiang, Etienne Melese, Catriona H.M. Jamieson, RNA rewriting, recoding, and rewiring in human disease, Trends in Molecular Medicine, 2015, 21, 9, 549

    CrossRef

  7. 7
    Sahar Elsayed El-Swefy, Hebatallah Husseini Atteia, The Mediterranean Diet, 2015,

    CrossRef

  8. 8
    Hanaâ Lahrach, Fadwa Essiarab, Mohammed Timinouni, Bachir Hatim, Salma El Khayat, Loubna Er-Rachdi, Jamal Jarir, Anas Kettani, Noreddine Ghalim, Hassan Taki, Halima Lebrazi, Benyounes Ramdani, Rachid Saïle, Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in patients on long-term hemodialysis, Renal Failure, 2014, 36, 10, 1504

    CrossRef

  9. 9
    David A. Raichlen, Gene E. Alexander, Exercise, APOE genotype, and the evolution of the human lifespan, Trends in Neurosciences, 2014, 37, 5, 247

    CrossRef

  10. 10
    Inna Gaisler-Salomon, Efrat Kravitz, Yulia Feiler, Michal Safran, Anat Biegon, Ninette Amariglio, Gideon Rechavi, Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease, Neurobiology of Aging, 2014, 35, 8, 1785

    CrossRef

  11. You have free access to this content11
    J. Hardy, N. Bogdanovic, B. Winblad, E. Portelius, N. Andreasen, A. Cedazo-Minguez, H. Zetterberg, Pathways to Alzheimer's disease, Journal of Internal Medicine, 2014, 275, 3
  12. 12
    Yiran Xu, Honglian Wang, Yanyan Sun, Qing Shang, Mingjie Chen, Tongchuan Li, Dengna Zhu, Lin He, Changlian Zhu, Qinghe Xing, The association of apolipoprotein E gene polymorphisms with cerebral palsy in Chinese infants, Molecular Genetics and Genomics, 2014, 289, 3, 411

    CrossRef

  13. 13
    Clara Ibáñez, Carolina Simó, Alejandro Cifuentes, Metabolomics in Alzheimer's disease research, ELECTROPHORESIS, 2013, 34, 19
  14. 14
    Kristin M Pearson-Fuhrhop, Steven C Cramer, Pharmacogenetics of neural injury recovery, Pharmacogenomics, 2013, 14, 13, 1635

    CrossRef

  15. 15
    R. O. Carare, C. A. Hawkes, M. Jeffrey, R. N. Kalaria, R. O. Weller, Review: Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy, Neuropathology and Applied Neurobiology, 2013, 39, 6
  16. 16
    I. Dafnis, A.K. Tzinia, E.C. Tsilibary, V.I. Zannis, A. Chroni, An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines, Neuroscience, 2012, 210, 21

    CrossRef

  17. 17
    Jitka Rynekrova, Dita Kasparova, Vera Adamkova, Tomas Fait, Jaroslav A. Hubacek, Analysis of the Potential Role of Apolipoprotein E Polymorphism in Genetic Predisposition to Spontaneous Abortion, American Journal of Reproductive Immunology, 2012, 67, 3
  18. 18
    Ximena S. Rossello, Urule Igbavboa, Gary A. Weisman, Grace Y. Sun, W. Gibson Wood, AP-2β regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytes, Brain Research, 2012, 1444, 87

    CrossRef

  19. 19
    May A. Beydoun, Adel Boueiz, Marwan S. Abougergi, Melissa H. Kitner-Triolo, Hind A. Beydoun, Susan M. Resnick, Richard O'Brien, Alan B. Zonderman, Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline, Neurobiology of Aging, 2012, 33, 4, 720

    CrossRef

  20. 20
    Aaron J. Trachtenberg, Nicola Filippini, Clare E. Mackay, The effects of APOE-ε4 on the BOLD response, Neurobiology of Aging, 2012, 33, 2, 323

    CrossRef

  21. 21
    Clara Ibáñez, Carolina Simó, Pedro J. Martín-Álvarez, Miia Kivipelto, Bengt Winblad, Angel Cedazo-Mínguez, Alejandro Cifuentes, Toward a Predictive Model of Alzheimer’s Disease Progression Using Capillary Electrophoresis–Mass Spectrometry Metabolomics, Analytical Chemistry, 2012, 84, 20, 8532

    CrossRef

  22. 22
    Hyman M. Schipper, Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment, Neurobiology of Aging, 2011, 32, 5, 778

    CrossRef

  23. 23
    Jeffrey L. Cummings, Biomarkers in Alzheimer's disease drug development, Alzheimer's & Dementia, 2011, 7, 3, e13

    CrossRef

  24. 24
    R.A.F. Weijenberg, E.J.A. Scherder, F. Lobbezoo, Mastication for the mind—The relationship between mastication and cognition in ageing and dementia, Neuroscience & Biobehavioral Reviews, 2011, 35, 3, 483

    CrossRef

  25. 25
    Angel Cedazo-Mínguez, Muhammad-Al-Mustafa Ismail, Laura Mateos, Plasma cholesterol and risk for late-onset Alzheimer’s disease, Expert Review of Neurotherapeutics, 2011, 11, 4, 495

    CrossRef

  26. 26
    Valerio Leoni, Claudio Caccia, Relationship between cholesterol metabolism, ApoE and brain volumes in Alzheimer’s disease, Future Neurology, 2011, 6, 5, 613

    CrossRef

  27. 27
    Arezoo Assareh, Karen A. Mather, Peter R. Schofield, John B.J. Kwok, Perminder S. Sachdev, The Genetics of White Matter Lesions, CNS Neuroscience & Therapeutics, 2011, 17, 5
  28. 28
    Iris Grossman, Michael W. Lutz, Donna G. Crenshaw, Ann M. Saunders, Daniel K. Burns, Allen D. Roses, Alzheimer’s disease: diagnostics, prognostics and the road to prevention, EPMA Journal, 2010, 1, 2, 293

    CrossRef

  29. 29
    Stephen A Spector, Kumud K Singh, Saurabh Gupta, Lucette A Cystique, Hua Jin, Scott Letendre, Rachel Schrier, Zunyou Wu, Kun X Hong, Xin Yu, Chuan Shi, Robert K Heaton, APOE ϵ4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors, AIDS, 2010, 24, 10, 1471

    CrossRef

  30. 30
    H.A.D. Keage, F.E. Matthews, A. Yip, L. Gao, C. McCracken, I.G. McKeith, D.C. Rubinsztein, C. Brayne, APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study, Age and Ageing, 2010, 39, 1, 104

    CrossRef

  31. 31
    Jian Hao, Wei Zhang, Peng Zhang, Rui Liu, Linna Liu, Gesheng Lei, Changjun Su, Jianting Miao, Zhuyi Li, Aβ20–29 peptide blocking apoE/Aβ interaction reduces full-length Aβ42/40 fibril formation and cytotoxicity in vitro, Neuropeptides, 2010, 44, 4, 305

    CrossRef

  32. 32
    Liang Wang, Yanbing Han, Dan Chen, Zheng Xiao, Zhiqin Xi, Fei Xiao, Xuefeng Wang, Cerebrospinal fluid apolipoprotein E concentration decreases after seizure, Seizure, 2010, 19, 2, 79

    CrossRef

  33. 33
    Aurelia Santoro, Paola Siviero, Nadia Minicuci, Elena Bellavista, Michele Mishto, Fabiola Olivieri, Francesca Marchegiani, Andrea Maria Chiamenti, Luisa Benussi, Roberta Ghidoni, Benedetta Nacmias, Silvia Bagnoli, Andrea Ginestroni, Osvaldo Scarpino, Emidio Feraco, Walter Gianni, Guido Cruciani, Roberto Paganelli, Angelo Di Iorio, Mario Scognamiglio, Luigi Maria Edoardo Grimaldi, Carlo Gabelli, Sandro Sorbi, Giuliano Binetti, Gaetano Crepaldi, Claudio Franceschi, Effects of Donepezil, Galantamine and Rivastigmine in 938 Italian Patients with Alzheimerʼs Disease, CNS Drugs, 2010, 24, 2, 163

    CrossRef

  34. You have full text access to this Open Access content34
    Per Nilsson, Nobuhisa Iwata, Shin-ichi Muramatsu, Lars O. Tjernberg, Bengt Winblad, Takaomi C. Saido, Gene therapy in Alzheimer’s disease – potential for disease modification, Journal of Cellular and Molecular Medicine, 2010, 14, 4
  35. 35
    Kristin M. Pearson-Fuhrhop, Steven C. Cramer, Genetic Influences on Neural Plasticity, PM&R, 2010, 2, 12, S227

    CrossRef

  36. 36
    Jonatan R. Ruiz, Ruth Castillo, Idoia Labayen, Luis A. Moreno, Miguel García Fuentes, Domingo González Lamuño, Jesus L. Alvarez Granda, Alejandro Lucia, Francisco B. Ortega, Individual and Combined Effects of ApoE and MTHFR 677C/T Polymorphisms on Cognitive Performance in Spanish Adolescents: The AVENA Study, The Journal of Pediatrics, 2010, 156, 6, 978

    CrossRef

  37. You have full text access to this Open Access content37
    Marina Hermes, Gerhard Eichhoff, Olga Garaschuk, Intracellular calcium signalling in Alzheimer’s disease, Journal of Cellular and Molecular Medicine, 2010, 14, 1-2
  38. 38
    Gjumrakch Aliev, Hector H. Palacios, Eldar Gasimov, Mark E. Obrenovich, Ludis Morales, Jerzy Leszek, Valentin Bragin, Arturo Solís Herrera, Dmitry Gokhman, Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease, Pharmaceuticals, 2010, 3, 1, 158

    CrossRef

  39. 39
    M. Gill, G. Donohoe, A. Corvin, What have the genomics ever done for the psychoses?, Psychological Medicine, 2010, 40, 04, 529

    CrossRef

  40. 40
    Lee-Fay Low, Melvyn H.W. Yap, Henry Brodaty, Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review, Neuroscience & Biobehavioral Reviews, 2010, 34, 3, 408

    CrossRef

  41. 41
    Patrick M Moriarty, Association of ApoE and HDL-C with cardiovascular and cerebrovascular disease: potential benefits of LDL-apheresis therapy, Clinical Lipidology, 2009, 4, 3, 311

    CrossRef

  42. 42
    Bogdan O. Popescu, Emil C. Toescu, Laurenţiu M. Popescu, Ovidiu Bajenaru, Dafin F. Muresanu, Marianne Schultzberg, Nenad Bogdanovic, Blood-brain barrier alterations in ageing and dementia, Journal of the Neurological Sciences, 2009, 283, 1-2, 99

    CrossRef

  43. 43
    Gjumrakch Aliev, Hector H. Palacios, Brianna Walrafen, Amanda E. Lipsitt, Mark E. Obrenovich, Ludis Morales, Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease, The International Journal of Biochemistry & Cell Biology, 2009, 41, 10, 1989

    CrossRef

  44. 44
    Kristin M. Pearson-Fuhrhop, Jeffrey A. Kleim, Steven C. Cramer, Brain Plasticity and Genetic Factors, Topics in Stroke Rehabilitation, 2009, 16, 4, 282

    CrossRef

  45. 45
    John Koren, Umesh K. Jinwal, Daniel C. Lee, Jeffrey R. Jones, Cody L. Shults, Amelia G. Johnson, Laura J. Anderson, Chad A. Dickey, Chaperone signalling complexes in Alzheimer's disease, Journal of Cellular and Molecular Medicine, 2009, 13, 4
  46. 46
    Ian J. Martins, Tamar Berger, Matthew J. Sharman, Giuseppe Verdile, Stephanie J. Fuller, Ralph N. Martins, Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease, Journal of Neurochemistry, 2009, 111, 6
  47. 47
    Amy Chan, Flaubert Tchantchou, Eugene J. Rogers, Thomas B. Shea, Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S-adenosyl methionine, Journal of Neurochemistry, 2009, 110, 3
  48. 48
    Christine Boesch-Saadatmandi, Siegfried Wolffram, Anne Marie Minihane, Gerald Rimbach, Effect of apoE genotype and dietary quercetin on blood lipids and TNF-α levels in apoE3 and apoE4 targeted gene replacement mice, British Journal of Nutrition, 2009, 101, 10, 1440

    CrossRef

  49. 49
    Karsten Ruscher, Emelie Johannesson, Elena Brugiere, Agnes Erickson, Mattias Rickhag, Tadeusz Wieloch, Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke, Journal of Cerebral Blood Flow & Metabolism, 2009, 29, 11, 1796

    CrossRef

  50. 50
    Jingyu Liu, Kent A. Kiehl, Godfrey Pearlson, Nora I. Perrone-Bizzozero, Tom Eichele, Vince D. Calhoun, Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response, NeuroImage, 2009, 46, 3, 809

    CrossRef

  51. 51
    Radjini Racine, Yann Gueguen, Patrick Gourmelon, Georges Veyssiere, Maâmar Souidi, Modifications of the Expression of Genes Involved in Cerebral Cholesterol Metabolism in the Rat Following Chronic Ingestion of Depleted Uranium, Journal of Molecular Neuroscience, 2009, 38, 2, 159

    CrossRef

  52. 52
    Alessia Tarditi, Andrea Caricasole, Georg Terstappen, Therapeutic targets for Alzheimer's disease, Expert Opinion on Therapeutic Targets, 2009, 13, 5, 551

    CrossRef

  53. 53
    Rick A.C.M. Boonen, Paula van Tijn, Danica Zivkovic, Wnt signaling in Alzheimer's disease: Up or down, that is the question, Ageing Research Reviews, 2009, 8, 2, 71

    CrossRef

  54. 54
    Rashid Deane, Abhay Sagare, Katie Hamm, Margaret Parisi, Steven Lane, Mary Beth Finn, David M. Holtzman, Berislav V. Zlokovic, apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain, Journal of Clinical Investigation, 2008, 118, 12, 4002

    CrossRef

  55. You have full text access to this Open Access content55
    Kurt A. Jellinger, Bernd Janetzky, Johannes Attems, Elisabeth Kienzl, Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?, Journal of Cellular and Molecular Medicine, 2008, 12, 4
  56. You have full text access to this Open Access content56
    Bogdan O. Popescu, Still debating a cause and diagnostic criteria for Alzheimer's disease, Journal of Cellular and Molecular Medicine, 2007, 11, 6